ロード中...
A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-α Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy
The peroxisome proliferator-activated receptor-α (PPAR-α) agonist fenofibrate ameliorates cardiac hypertrophy; however, its mechanism of action has not been completely determined. Our previous study indicated that a disintegrin and metalloproteinase-17 (ADAM17) is required for angiotensin II-induced...
保存先:
| 出版年: | PPAR Res |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6076894/ https://ncbi.nlm.nih.gov/pubmed/30105051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7916953 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|